Oaktree Capital Management, the American global asset management firm specializing in alternative investment strategies, has raised more than $2.3 billion for its first private credit fund dedicated to life sciences companies.

The Fund, which is Oaktree's first dedicated life sciences fund, was oversubscribed said a press release from the investment manager with